Please login to the form below

Not currently logged in
Email:
Password:

Antibody Oligonucleotide Conjugates

This page shows the latest Antibody Oligonucleotide Conjugates news and features for those working in and with pharma, biotech and healthcare.

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Lilly invests in antibody oligonucleotides conjugates with Avidity deal

Companies to develop new immonology medicines. Eli Lilly is aiming to develop new immunology drugs based on DNA/RNA molecules, and has enlisted the help of antibody oligonucleotide conjugates (AOC) specialist ... However a big obstacle in the class is

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Mind+Matter

We are Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for our...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...